Litcius/Paper detail

Symptomatic Care in Multiple System Atrophy: State of the Art

Anna Grossauer, Victoria Sidoroff, Beatrice Heim, Klaus Seppi

2022The Cerebellum17 citationsDOIOpen Access PDF

Abstract

Without any disease-modifying treatment strategy for multiple system atrophy (MSA), the therapeutic management of MSA patients focuses on a multidisciplinary strategy of symptom control. In the present review, we will focus on state of the art treatment in MSA and additionally give a short overview about ongoing randomized controlled trials in this field.

Topics & Concepts

Multidisciplinary approachAtrophyMedicineNeurologyRandomized controlled trialIntensive care medicinePhysical medicine and rehabilitationPsychologyPathologyPsychiatryPolitical scienceLawParkinson's Disease Mechanisms and TreatmentsGenetic Neurodegenerative DiseasesNuclear Receptors and Signaling
Symptomatic Care in Multiple System Atrophy: State of the Art | Litcius